Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.

Sarah Wood, Nadia Dowshen, José A Bauermeister, Linden Lalley-Chareczko, Joshua Franklin, Danielle Petsis, Meghan Swyryn, Kezia Barnett, Gary E Weissman, Helen C Koenig, Robert Gross
Author Information
  1. Sarah Wood: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Electronic address: woodsa@email.chop.edu.
  2. Nadia Dowshen: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  3. José A Bauermeister: School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania.
  4. Linden Lalley-Chareczko: Philadelphia FIGHT Community Health Centers, Philadelphia, Pennsylvania.
  5. Joshua Franklin: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  6. Danielle Petsis: Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  7. Meghan Swyryn: Philadelphia FIGHT Community Health Centers, Philadelphia, Pennsylvania.
  8. Kezia Barnett: Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  9. Gary E Weissman: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  10. Helen C Koenig: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Philadelphia FIGHT Community Health Centers, Philadelphia, Pennsylvania.
  11. Robert Gross: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

Abstract

PURPOSE: The aim of the study was to characterize perceived social support for young men and transgender women who have sex with men (YM/TWSM) taking HIV pre-exposure prophylaxis (PrEP).
METHODS: Mixed-methods study of HIV-negative YM/TWSM of color prescribed oral PrEP. Participants completed egocentric network inventories characterizing their social support networks and identifying PrEP adherence support figures. A subset (n = 31) completed semistructured interviews exploring adherence support and qualities of PrEP support figures. We calculated proportions of role types (e.g., family), individuals disclosed to regarding PrEP use, and PrEP-supportive individuals within each participant network. Interviews were analyzed using an inductive approach.
RESULTS: Participants (n = 50) were predominately African American men who have sex with men. Median age was 22 years (interquartile range: 20-23). Biologic family were the most common support figures, reported by 75% of participants (mean family proportion .37 [standard deviation (SD): .31]), followed by 67% reporting friends (mean friend proportion .38 [SD: .36]). Most network members were aware (mean disclosed proportion .74 [SD: .31]) and supportive (mean supportive proportion .87 [SD: .28]) of the participants' PrEP use. Nearly all (98%) participants identified ≥1 figure who provided adherence support; more often friends (48%) than family (36%). Participants characterized support as instrumental (e.g., transportation); emotional (e.g., affection); and social interaction (e.g., taking medication together). Key characteristics of PrEP support figures included closeness, dependability, and homophily (alikeness) with respect to sexual orientation.
CONCLUSIONS: Although most YM/TWSM identified family in their support networks, friends were most often cited as PrEP adherence support figures. Interventions to increase PrEP adherence should consider integrated social network and family-based approaches.

Keywords

References

  1. Health Serv Outcomes Res Methodol. 2008 Dec 1;8(4):222-269 [PMID: 20046802]
  2. JAMA Pediatr. 2017 Nov 1;171(11):1063-1071 [PMID: 28873128]
  3. Sex Res Social Policy. 2018 Jun;15(2):123-138 [PMID: 29713394]
  4. AIDS Behav. 2016 Nov;20(11):2739-2761 [PMID: 26837634]
  5. Ann Epidemiol. 2018 Dec;28(12):841-849 [PMID: 29983236]
  6. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29 [PMID: 27632233]
  7. AIDS Care. 2015;27(5):637-41 [PMID: 25430940]
  8. J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S54-8 [PMID: 23673888]
  9. Phys Rev Lett. 2002 Nov 11;89(20):208701 [PMID: 12443515]
  10. Lancet. 2016 Jan 2;387(10013):53-60 [PMID: 26364263]
  11. NCHS Data Brief. 2016 Dec;(266):1-8 [PMID: 27996934]
  12. Lancet Infect Dis. 2014 Sep;14(9):820-9 [PMID: 25065857]
  13. Am J Public Health. 2016 Aug;106(8):1511-3 [PMID: 27310349]
  14. J Gay Lesbian Soc Serv. 2014 Jan 1;26(3):279-302 [PMID: 25214756]
  15. AIDS Behav. 2014 Nov;18(11):2156-68 [PMID: 24980248]
  16. J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):24-30 [PMID: 30365451]
  17. HIV AIDS (Auckl). 2015 Oct 13;7:241-9 [PMID: 26508889]
  18. J Sex Res. 2017 May -Jun;54(4-5):532-548 [PMID: 28059568]
  19. Am J Public Health. 2010 Oct;100(10):1953-60 [PMID: 20516373]
  20. AIDS Behav. 2015 Jun;19(6):1037-47 [PMID: 25430501]
  21. J Health Psychol. 1997 Jul;2(3):335-51 [PMID: 22013026]
  22. Arch Pediatr Adolesc Med. 2012 Feb;166(2):127-33 [PMID: 21969363]
  23. J Child Adolesc Psychiatr Nurs. 2010 Nov;23(4):205-13 [PMID: 21073595]
  24. Prev Sci. 2016 Feb;17(2):248-58 [PMID: 26459373]
  25. Soc Sci Med. 2005 Oct;61(7):1576-96 [PMID: 16005789]
  26. J Infect Dis. 2016 Dec 15;214(12):1800-1807 [PMID: 27418048]
  27. J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):627-35 [PMID: 23011395]
  28. AIDS Behav. 2017 May;21(5):1376-1382 [PMID: 28238119]
  29. AIDS Behav. 2018 Nov;22(11):3673-3680 [PMID: 29754268]
  30. Trends Ecol Evol. 2011 Oct;26(10):502-7 [PMID: 21715042]
  31. Glob Public Health. 2018 Feb;13(2):144-158 [PMID: 27169632]
  32. J Sex Res. 2015;52(7):807-20 [PMID: 24992185]

Grants

  1. P30 AI045008/NIAID NIH HHS
  2. P30 MH097488/NIMH NIH HHS
  3. F32 MH111341/NIMH NIH HHS
  4. K23 MH102128/NIMH NIH HHS
  5. K23 MH119976/NIMH NIH HHS

MeSH Term

Administration, Oral
Anti-HIV Agents
Ethnicity
Female
HIV Infections
Homosexuality, Male
Humans
Male
Medication Adherence
Pre-Exposure Prophylaxis
Self Efficacy
Sexual and Gender Minorities
Social Support
Transgender Persons
Young Adult

Chemicals

Anti-HIV Agents